Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-038999
Filing Date
2025-03-14
Accepted
2025-03-13 19:14:28
Documents
122
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rgen-20241231.htm   iXBRL 10-K 4509515
2 EX-21.1 rgen-ex21_1.htm EX-21.1 22927
3 EX-23.1 rgen-ex23_1.htm EX-23.1 6590
4 EX-31.1 rgen-ex31_1.htm EX-31.1 13327
5 EX-31.2 rgen-ex31_2.htm EX-31.2 13319
6 EX-32.1 rgen-ex32_1.htm EX-32.1 16647
7 GRAPHIC img34541710_0.jpg GRAPHIC 614959
  Complete submission text file 0000950170-25-038999.txt   23292937

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgen-20241231.xsd EX-101.SCH 2799377
125 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20241231_htm.xml XML 5045065
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 25737275
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)